Please use this identifier to cite or link to this item:
Title: Utilizing experimental mouse model to identify effectors of hepatocellular carcinoma induced by HBx antigen
Authors: Yang, M.-H.
Chen, M.
Mo, H.-H.
Tsai, W.-C.
Chang, Y.-C.
Chang, C.-C.
Chen, K.-C.
Wu, H.-Y.
Yuan, C.-H. 
Lee, C.-H.
Chen, Y.-M.A.
Tyan, Y.-C.
Keywords: HBx
Hepatocellular carcinoma
Missing proteins
Issue Date: 2020
Publisher: MDPI AG
Citation: Yang, M.-H., Chen, M., Mo, H.-H., Tsai, W.-C., Chang, Y.-C., Chang, C.-C., Chen, K.-C., Wu, H.-Y., Yuan, C.-H., Lee, C.-H., Chen, Y.-M.A., Tyan, Y.-C. (2020). Utilizing experimental mouse model to identify effectors of hepatocellular carcinoma induced by HBx antigen. Cancers 12 (2) : 409. ScholarBank@NUS Repository.
Rights: Attribution 4.0 International
Abstract: Hepatocellular carcinoma (HCC) is among the ten most commonly diagnosed cancers and the fourth leading cause of cancer-related death. Patients with hepatitis B virus (HBV) infection are prone to developing chronic liver diseases (i.e., fibrosis and cirrhosis), and the HBV X antigen plays an important role in the development of HCC. The difficulty in detecting HCC at the early stages is one of the main reasons that the death rate approximates the incidence rate. The regulators controlling the downstream liver protein expression from HBV infection are unclear. Mass spectrometric techniques and customized programs were used to identify differentially expressed proteins which may be involved in the development of liver fibrosis and HCC progression in hepatitis B virus X protein transgenic mice (HBx mice). FSTL1, CTSB, and TGF-β enhanced the signaling pathway proteins during the pathogenesis of HBx. Missing proteins can be essential in cell growth, differentiation, apoptosis, migration, metastasis or angiogenesis. We found that LHX2, BMP-5 and GDF11 had complex interactions with other missing proteins and BMP-5 had both tumor suppressing and tumorigenic roles. BMP-5 may be involved in fibrosis and tumorigenic processes in the liver. These results provide us an understanding of the mechanism of HBx-induced disorders, and may serve as molecular targets for liver treatment. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.
Source Title: Cancers
ISSN: 2072-6694
DOI: 10.3390/cancers12020409
Rights: Attribution 4.0 International
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3390_cancers12020409.pdf2.71 MBAdobe PDF




checked on Mar 25, 2023

Page view(s)

checked on Mar 30, 2023

Google ScholarTM



This item is licensed under a Creative Commons License Creative Commons